BTAI Competitors & Alternatives

Compare BioXcel Therapeutics Inc with similar stocks in the same industry

Drug Manufacturers - Specialty & Generic

BTAI

Main Stock
$0.07
Tradestie Score
56
Market Cap
$50.49M
Revenue Growth
0.5%
Analyst Upside
+28993.4%

Top Competitors

46 stocks in Drug Manufacturers - Specialty & Generic
Company Price Market Cap P/E Score Action
COLL Collegium Pharmaceutical, Inc. Common Stock
$24.95
$1.11B 22.8 38 Compare
CRON Cronos Group Inc. Common Share
$3.41
$1.02B 21.6 55 Compare
ESPR Esperion Therapeutics, Inc.
$3.18
$584.71M - 53 Compare
ETON Eton Pharmaceutcials, Inc. Common Stock
$61.45
$543.32M 43.8 40 Compare
TKNO Alpha Teknova, Inc. Common Stock
$8.30
$340.89M - 38 Compare
ALLO Allogene Therapeutics, Inc. Common Stock
$0.83
$275.13M - 41 Compare
IRWD Ironwood Pharmaceuticals, Inc. - Class A
$4.85
$237.15M 5.4 38 Compare
ATRA Atara Biotherapeutics, Inc
$7.93
$101.48M - 51 Compare
KPTI Karyopharm Therapeutics Inc.
$0.02
$53.85M - 48 Compare
KYNB KYNB
$3.59
- - 46 Compare

Data updated: Nov 12, 2026 | Industry: Drug Manufacturers - Specialty & Generic (SIC 2834)

46 stocks in this industry